Drug Profile
SOL 924
Alternative Names: SOL924Latest Information Update: 28 Jan 2018
Price :
$50
*
At a glance
- Originator Solural Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jan 2018 No recent reports of development identified for phase-I development in Undefined in Denmark (PO)
- 02 Dec 2014 Phase-I clinical trials in Undefined indication in Denmark (PO)